[go: up one dir, main page]

MX2008012731A - Tabletas de paracetamol de liberacion rapida. - Google Patents

Tabletas de paracetamol de liberacion rapida.

Info

Publication number
MX2008012731A
MX2008012731A MX2008012731A MX2008012731A MX2008012731A MX 2008012731 A MX2008012731 A MX 2008012731A MX 2008012731 A MX2008012731 A MX 2008012731A MX 2008012731 A MX2008012731 A MX 2008012731A MX 2008012731 A MX2008012731 A MX 2008012731A
Authority
MX
Mexico
Prior art keywords
fast release
paracetamol tablets
release paracetamol
tablets
paracetamol
Prior art date
Application number
MX2008012731A
Other languages
English (en)
Inventor
Hemant H Alur
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX2008012731A publication Critical patent/MX2008012731A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe una composición farmacéutica, tal como una formulación de tableta o cápsula para tragar, que comprende paracetamol, carbonato de calcio, cuando menos un agente aglutinante, y cuando menos un agente desintegrante en la forma de un granulado, opcionalmente combinados con uno o más componentes extragranulares farmacéuticamente aceptables.
MX2008012731A 2006-04-07 2007-04-03 Tabletas de paracetamol de liberacion rapida. MX2008012731A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0607085.8A GB0607085D0 (en) 2006-04-07 2006-04-07 Novel compositions
PCT/US2007/065829 WO2007118063A1 (en) 2006-04-07 2007-04-03 Fast release paracetamol tablets

Publications (1)

Publication Number Publication Date
MX2008012731A true MX2008012731A (es) 2008-10-14

Family

ID=36539581

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008012731A MX2008012731A (es) 2006-04-07 2007-04-03 Tabletas de paracetamol de liberacion rapida.

Country Status (15)

Country Link
US (1) US8461210B2 (es)
EP (1) EP2010159B1 (es)
CN (1) CN101466359B (es)
AU (1) AU2007234864B2 (es)
BR (1) BRPI0709847B8 (es)
CA (1) CA2648725A1 (es)
CR (1) CR10349A (es)
DK (1) DK2010159T3 (es)
EA (1) EA017157B1 (es)
GB (1) GB0607085D0 (es)
MX (1) MX2008012731A (es)
MY (1) MY147641A (es)
NO (1) NO20084065L (es)
NZ (1) NZ571624A (es)
WO (1) WO2007118063A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
EP2493457B1 (en) 2009-10-30 2017-08-09 IX Biopharma Ltd Fast dissolving solid dosage form
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
WO2011135106A1 (es) * 2010-04-26 2011-11-03 Smart Pharma Solutions, S.L Granulado altamente dispersable para la preparación de formulaciones de sustancias activas de altas dosis y procedimiento de obtención del mismo
US9446000B2 (en) * 2011-09-08 2016-09-20 Masdar Institute Of Science And Technology Cellulosic gel material as a pharmaceutical excipient
US20140128415A1 (en) * 2012-05-30 2014-05-08 Paul Daniel Yered Excipient drug composition
CN103110637B (zh) * 2013-02-19 2014-07-30 青岛正大海尔制药有限公司 酚咖胶囊及其制备方法
BE1021194B1 (nl) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba Paracetamol tabletten
CN105310990B (zh) * 2014-12-04 2018-01-19 蚌埠丰原涂山制药有限公司 一种防止粘冲和裂片的对乙酰氨酚片及其制备方法
BE1023116B1 (nl) * 2015-07-24 2016-11-23 Nordic Specialty Pharma Bvba Paracetamol omvattend preparaat met vertraagde en aanhoudende afgifte
CN105055329A (zh) * 2015-08-05 2015-11-18 安丘市鲁安药业有限责任公司 复合扑热息痛速溶颗粒及其制备方法
CN106265573A (zh) * 2016-09-23 2017-01-04 广东岭南职业技术学院 一种扑热息痛片生产中hpmc浆的制备工艺
CN108451916B (zh) * 2018-06-19 2020-08-14 重庆国泰康宁制药有限责任公司 一种对乙酰氨基酚药物组合物制剂及其制备方法
CN108853038A (zh) * 2018-08-06 2018-11-23 成都通德药业有限公司 一种对乙酰氨基酚片及其制备工艺
CN111374953A (zh) * 2018-12-31 2020-07-07 上海鼎雅药物化学科技有限公司 对乙酰氨基酚片及其制备工艺
EP3679926A1 (en) * 2019-01-14 2020-07-15 APTYS Pharmaceuticals SAS A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby
CN110101672A (zh) * 2019-05-07 2019-08-09 安徽金太阳生化药业有限公司 一种对乙酰氨基酚片及其制备方法
CN111012750A (zh) * 2019-12-27 2020-04-17 北京济美堂医药研究有限公司 一种对乙酰氨基酚片及其制备方法
GB202007670D0 (en) 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition
CN114129524A (zh) * 2021-09-30 2022-03-04 山东齐都药业有限公司 对乙酰氨基酚片剂及其制备方法
CN114432256A (zh) * 2021-12-31 2022-05-06 陕西必康制药集团控股有限公司 对乙酰氨基酚包衣片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
CA2009326C (en) * 1989-05-09 1998-01-27 Lawrence J. Daher Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
ES2624585T3 (es) 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2005247047C1 (en) 2004-05-28 2010-03-11 Glaxo Group Limited Oral delivery system
RU2398571C2 (ru) 2004-10-28 2010-09-10 Новартис Аг Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system

Also Published As

Publication number Publication date
EP2010159A1 (en) 2009-01-07
EA200801926A1 (ru) 2009-04-28
CR10349A (es) 2008-11-26
MY147641A (en) 2012-12-31
BRPI0709847B1 (pt) 2020-09-15
AU2007234864B2 (en) 2012-11-22
NZ571624A (en) 2011-11-25
CN101466359A (zh) 2009-06-24
AU2007234864A1 (en) 2007-10-18
BRPI0709847A2 (pt) 2011-07-26
EA017157B1 (ru) 2012-10-30
DK2010159T3 (da) 2012-10-22
WO2007118063A1 (en) 2007-10-18
BRPI0709847B8 (pt) 2021-05-25
CA2648725A1 (en) 2007-10-18
GB0607085D0 (en) 2006-05-17
US20090170955A1 (en) 2009-07-02
EP2010159B1 (en) 2012-08-22
US8461210B2 (en) 2013-06-11
NO20084065L (no) 2008-10-30
CN101466359B (zh) 2013-09-25

Similar Documents

Publication Publication Date Title
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
IL181382A0 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
AU2010308458A8 (en) Orally transformable tablets
MX2010007609A (es) Formulacion de capsula.
MX343358B (es) Tabletas de acetato de ulipristal.
WO2008014175A3 (en) Granular pharmaceutical compositions
CO6440564A2 (es) Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
BRPI0606883A2 (pt) composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única
IL187475A (en) A form of oral administration containing one population of micro-particles to release a variable of at least one active anesthetic and a second population of micro-particles containing at least one depressant and their use
WO2007143155A3 (en) Sustained release pharmaceutical dosage form containing phenylephrine
MX2010007083A (es) Combinacion anti-retroviral.
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
WO2010132095A8 (en) Method and composition to improve absorption of therapeutic agents
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
WO2008005353A3 (en) Immediate-release tablet formulations of a thrombin receptor antagonist
MX2007002898A (es) Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BG109430A (en) FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION
WO2008038155A3 (en) Controlled-release pharmaceutical tablets
ZA200506992B (en) Fibrate tablet and method for the production thereof
EA200601283A1 (ru) Фармацевтическая композиция с контролируемым высвобождением, содержащая нерастворимый в кислотах полимер и биоадгезивный полимер
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa

Legal Events

Date Code Title Description
FG Grant or registration